Compare Lustrum:WAKAMOTO PHARMACEUTICAL CO.,LTD.:4512

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index WAKAMOTO PHARMACEUTICAL CO.,LTD. Go to web site 4512 Medicals 東証スタンダード March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2024年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
3,665down
(23.8%)down
3,879up
(24.7%)up
3,232up
(21.6%)up
2,844down
(19.5%)up
2,884
(18.0%)
Other Current AssetsHelp
(Percent)
5,305down
(34.4%)down
5,474up
(34.8%)down
5,376up
(36.0%)up
4,794down
(32.9%)down
5,764
(36.1%)
Tangible Fixed AssetsHelp
(Percent)
3,028down
(19.6%)up
3,032down
(19.3%)down
3,297down
(22.1%)down
3,527down
(24.2%)up
3,648
(22.8%)
Intangible Fixed AssetHelp
(Percent)
357up
(2.3%)up
202up
(1.3%)down
196down
(1.3%)down
201down
(1.4%)down
485
(3.0%)
Investments and OthersHelp
(Percent)
3,066down
(19.9%)up
3,124up
(19.9%)up
2,852down
(19.1%)down
3,207up
(22.0%)up
3,202
(20.0%)
Total AssetsHelp
(Percent)
15,421
(100%)
15,712
(100%)
14,953
(100%)
14,572
(100%)
15,983
(100%)
Total Current LiabilitiesHelp
(Percent)
3,395down
(22.0%)down
3,804up
(24.2%)up
3,471up
(23.2%)up
3,184down
(21.9%)down
4,033
(25.2%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
1down
(0.0%)down
2down
(0.0%)down
3down
(0.0%)down
4
(0.0%)
Shareholder's EquityHelp
(Percent)
12,026up
(78.0%)up
11,907up
(75.8%)down
11,481up
(76.8%)down
11,386down
(78.1%)up
11,947
(74.7%)
Total LiabilitiesHelp
(Percent)
15,421
(100%)
15,712
(100%)
14,953
(100%)
14,572
(100%)
15,983
(100%)

WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2024年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
7,738
(100%)
8,660
(100%)
8,383
(100%)
8,896
(100%)
10,917
(100%)
Total Sales
(Percent)
7,738
(100%)
8,660
(100%)
8,383
(100%)
8,896
(100%)
10,917
(100%)
Cost of SalesHelp
(Percent)
4,139down
(53.5%)up
4,552up
(52.6%)up
4,027down
(48.0%)down
4,407down
(49.5%)up
4,724
(43.3%)
Other Costs and RevenueHelp 3,491down
(45.1%)down
3,970down
(45.8%)down
4,117down
(49.1%)down
5,091down
(57.2%)down
7,849
(71.9%)
Total CostsHelp 7,629 8,522 8,145 9,498 12,573
Net RevenueHelp 3,600down
(46.5%)down
4,108down
(47.4%)down
4,356down
(52.0%)up
4,489down
(50.5%)down
6,193
(56.7%)
Earnings Before TaxHelp 159down
(2.1%)down
212down
(2.4%)down
285up
(3.4%)up
-703up
(-7.9%)up
-911
(-8.3%)
Net IncomeHelp 109down
(1.4%)down
138down
(1.6%)down
239up
(2.8%)up
-602up
(-6.8%)up
-1,657
(-15.2%)
当期純利益 109 138 239 -602 -1,657

WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2024年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 WAKAMOTO PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
-107down
(-50.0%)down
632up
(97.4%)up
339up
(87.0%)up
163up
(80.4%)up
-155
(-41.0%)
Investing Cash Flow(ICF)Help
(Percent)
-2down
(-1.1%)down
17down
(2.6%)down
51up
(13.0%)up
-200down
(-98.1%)down
-179
(-47.3%)
Financing Cash FlowHelp
(Percent)
-105down
(-48.9%)down
-2up
(-0.2%)up
-2up
(-0.4%)up
-4up
(-1.9%)up
-44
(-11.7%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0down
(0.0%)down
0up
(0.0%)up
-0down
(0.0%)down
0up
(0.0%)up
-0
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn -215down
(-100.0%)down
647up
(99.8%)up
388up
(99.6%)up
-40up
(-19.6%)up
-378
(-100.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

WAKAMOTO PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

PeptiDream Inc.
ZERIA PHARMACEUTICAL CO.,LTD.
Fuso Pharmaceutical Industries, Ltd.
Shionogi & Co.,Ltd.
BrightPath Biotherapeutics Co., Ltd.
GNI Group Ltd.
Cyfuse Biomedical K.K.
Sumitomo Pharma Co., Ltd.
Eisai Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.